Opthea Advances Toward Sozinibercept Commercialization
PremiumCompany AnnouncementsOpthea Advances Toward Sozinibercept Commercialization
2M ago
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
2M ago
Opthea price target lowered to $10 from $12 at Citi
Premium
The Fly
Opthea price target lowered to $10 from $12 at Citi
2M ago
Opthea Limited Showcases Innovations at Investor Conferences
PremiumCompany AnnouncementsOpthea Limited Showcases Innovations at Investor Conferences
2M ago
Opthea price target lowered to $12 from $14 at H.C. Wainwright
Premium
The Fly
Opthea price target lowered to $12 from $14 at H.C. Wainwright
2M ago
Opthea reports FY24 adjusted EPS ($27.27) vs. ($30.61) last year
Premium
The Fly
Opthea reports FY24 adjusted EPS ($27.27) vs. ($30.61) last year
2M ago
Opthea announces publication on VEGF-C, VEGF-D signaling pathways
PremiumThe FlyOpthea announces publication on VEGF-C, VEGF-D signaling pathways
4M ago
Opthea’s Sozinibercept Shows Promise for Wet AMD
Premium
Company Announcements
Opthea’s Sozinibercept Shows Promise for Wet AMD
4M ago
Opthea looks to raise $150M via an $6.6M placement, $143.4M ANREO
Premium
The Fly
Opthea looks to raise $150M via an $6.6M placement, $143.4M ANREO
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100